<img src="https://ml.globenewswire.com/Resource/Download/6784a4a6-c259-489c-8b5b-05266f41b06f?size=2" nborder="0" align="left" hspace="5" vspace="5" title="HBIO Logo.png" alt="Harvard Bioscience, Inc."/>HOLLISTON, Mass., July 28, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2026, before the market opens on August 11, 2026, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.  Analysts who would like to join the call and ask a question must register <a href="https://www.globenewswire.com/Tracker?data=kh_SYM3qnQyRU1Dlna_HcJs500qjkDLyptFFR1Cie90CYs8gbIjevYWU6G2berGIB5ZSqyBmWCgp3imtOthRy3xgBFkCsrimKUHz59oBaOh7BV-RtYUMvlncsmQN3SvV9SWlRFN5mCSvbdVIjaUmWloc7i1YpqqQlCPLE8SD02A=" rel="nofollow" target="_blank" title="">here</a>. Once registered, you will receive the dial-in numbers and a unique PIN number.  Participants who would like to join the audio-only webcast should go to our events and presentations on the investor website <a href="https://www.globenewswire.com/Tracker?data=kh_SYM3qnQyRU1Dlna_HcIJJO7WtSFFMHx8_Abx5sTH5hcJPJhjwU-2uVunmGHb4fnMrlKTVQtitYGRiApJISZaUTBDdnOCzjOwWJ0Gh51NnocsBhPDD8iRRLYqNrKiy" rel="nofollow" target="_blank" title="">here</a>. Financial information presented on the call, including the earnings release and a related slide presentation, will be available on the <a href="https://www.globenewswire.com/Tracker?data=qo58dI-t3vpI6MFK9lznKBN0Bl4CneJ_mT6K0vB_fkSKOBQy9U2jQTwheEh7nOk2v6hyiGen1KDIze6txne5xDESh_htKaCuBsJtKAGMC4xDBO84G12cGqVLJw9fRLHF" rel="nofollow" target="_blank" title="">Investor Relations</a> section of Harvard Bioscience’s website.  About Harvard Bioscience  Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in the United States, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world. For more information, please visit our website at <a href="https://www.globenewswire.com/Tracker?data=ZCVE-ZF6Rabwb0Aq-tpKjiokS2yWRWnfwC9Y2yG6YRDNU7_zLkigvtUPV9Hvc40H4g9uCme3MDO-UV7psp6_FPwD_wnvK-21UWVS6sZaF9mNW6YZ6hYHms6_kM4UsKunjn-RGmpLa3SR-L4hN_jrzJ_Wg_rkVSUL73SmRLKd0QU1EvcHpKkvF_jrzzrk8Ud-1e5HAF59U0-hKzWBU2DnI2-in9EOfxSYho6m8IAl3q2yCAYDpwSuMMzlTUlPkE_V8wte4Vqnldqfrtn-gzAnU-jtMFmTvLmbCPIGxoLKjYWOkgcttx05RePcazvQdI6PRQaTyyBRVnyye4W9rnF0-CRNWJOioUp33uS0mys6hQYwf2UWtnxw9Gm50aXYqueugUdRcxdO-JQzCncEpIDPH0fuqPeRuEIjDqGvocGE15on4WUTe__tOmpLdv9AuWgMFKURIDzbzIe0NcXg26EViA==" rel="nofollow" target="_blank" title="www.harvardbioscience.com">www.harvardbioscience.com</a>. Company Contact: Mark Frost Chief Financial Officer (508) 893-3120 <a href="https://www.globenewswire.com/Tracker?data=P0B8UfqXuEnkWnpu2GVc6_w70Wh5q3vslDHjjvVTn87uFo70EV8jHIKCgpw8yr00zo6dCtApoUKf1H3KfGbucmNw2Dd-qqaa56LQb8jw2YaNLdyLa7ZcZjFzC5FxPgf0" rel="nofollow" target="_blank" title="investors@harvardbioscience.com">investors@harvardbioscience.com</a> <img alt="" src='https://ml.globenewswire.com/media/NzkyODBlNDMtNjg3Ni00OTk0LTg3NzUtMjI5YjBmNWI4MGI3LTEwMTcyMTctMjAyNi0wNy0yOC1lbg==/tiny/Harvard-Bioscience-Inc-.png' referrerpolicy='no-referrer-when-downgrade' />

GlobeNewswire Inc.

Harvard Bioscience Schedules Second Quarter 2026 Earnings Conference Call for August 11, 2026 at 8:00 AM ET

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn